Patient education has always been at the core of the nursing profession. Nurses pride themselves on being great teachers and patient advocates. When self-injectable biologics were first introduced to the market, one of the main goals was to make patients independent and put them in the driver’s seat of their own care. Yet without a…
The Rheumatology Research Foundation has infused more than $130 million into rheumatology research, education and training since it was established in 1985. The Foundation’s efforts have been greatly enhanced by the support of Corporate Roundtable (CRT) members. The CRT is a dynamic partnership between the Foundation and members of the pharmaceutical industry committed to furthering…
Meet the Foundation’s incoming president, Eric L. Matteson, MD, MPH. Dr. Matteson trained in rheumatology at the University of Michigan and Mayo Graduate School of Medicine, Mayo Clinic College of Medicine. He later earned his Master of Public Health in epidemiology at the University of North Carolina, Chapel Hill. Dr. Matteson currently works as the…
As usual, your items in The Rheumatologist remain timely. In the case of attracting medical students into rheumatology, your piece is also timeless. For many years now, I have recommended to various officers of the ACR that we obtain a list of students and their home addresses when they are admitted to medical school. At…
I want to thank you for writing the article, “Attracting More Medical Students to Rheumatology” for The Rheumatologist (online, October 2015). I am a senior at Georgetown University now, and I have recently applied to medical school. I have considered pursuing a career in rheumatology, and your article has inspired me to stay on that…
After its December meeting, the ACR Government Affairs Committee has determined the federal and state issues the College will focus its advocacy efforts on in 2016. These issues include ensuring implementation of the Medicare Access & CHIP Reauthorization Act of 2015 protects rheumatologists, creating an arthritis research program at the Department of Defense and more…
LONDON (Reuters)—The number of new drugs approved in the U.S. this year has already topped last year’s 18-year high, yet large pharmaceutical companies are still struggling to get a decent return on their research dollars. In fact, returns on research and development (R&D) spending by the world’s top drug makers have fallen to just 4.2%,…
NEW YORK (Reuters Health)—The “safety culture” of a hospital may be just as important in delivering high-quality surgical patient care as more technical issues like surgeon skill and operating room equipment, according to a new study. “The study supports what many surgeons have known for a long time, and that is that the organizational culture…
WASHINGTON/NEW YORK (Reuters)—Pharmaceuticals firm Valeant, under mounting pressure from Congress and prosecutors over its drug pricing, has hired an attorney in Washington, D.C., and crisis public relations experts with political connections, according to sources familiar with the matter. The move, confirmed by sources and through documents viewed by Reuters, signals a shift for Valeant Pharmaceuticals,…
In a study of patients with Charcot-Marie-Tooth disease, researchers found that MRI scans can be used to detect the muscle water changes that precede marked intramuscular fat accumulation that may contribute to the disease’s presentation. MRI biomarkers may prove useful in clinical trials for therapies for this and other neuromuscular disorders by enabling researchers to measure disease progression…